INVESTIGATION OF THE PHARMACEUTICAL FACTORS INFLUENCE ON TECHNOLOGICAL PROPERTIES OF THE COMPRESSION MIXTURE АND SOME QUALITY INDICATORS OF TABLETS BASED ON MALVA SYLVESTRIS L. AND PLANTAGO LANCEOLATA L. DRY EXTRACTS

Authors

  • S. Ya. Beley LLC «Ternofarm»
  • T. A. Hroshovyi I. Horbachevsky Ternopil State Medical University
  • N. M. Beley I. Horbachevsky Ternopil State Medical University

DOI:

https://doi.org/10.11603/2312-0967.2017.4.8377

Keywords:

pharmaceutical factors, technological properties, compression mixture, tablets, extracts of Malva sylvestris L. and Plantago lanceolata L.

Abstract

Aim. Study of the of the excipients influence on the process of wetting and granulation, mass loss, flowability and bulk density of the compression mixture, the compressing process and the tablets appearance in order to develop combined tablets based on Malva sylvestris flowers and Plantago lanceolata L. leaves dry extracts by method of wet granulation.

Materials and Methods. The main active substances are dry extracts of Malva sylvestris flowers and Plantago lanceolata leaves, 16 excipients – pharmaceutical factors. The tablets were obtained by the method of wet granulation. Investigation of the influence of excipients on the flowability and bulk density of compression mixture were carried out in accordance with the requirements of the State Pharmacopoeia.

Results and Discussion. In order to develop of the composition and technology of tablets based on Malva sylvestris L. and Plantago lanceolata L. dry extracts we had to select the optimal excipients: fillers, binders, disintegrants, moisture regulators. To study the influence of four factors and their levels on the technological properties of the compression mixture and the appearance of the tablets based on Malva sylvestris L. and Plantago lanceolata L. dry extracts, 4x4 Greek-Latin square has been used. Thus, the technological properties were the best when such excipient were used: MCC 101 and MCC 102; plasdon K-25alcohol solution, polyplazdon XL-10, silicon dioxide colloidal anhydrous, neuselin UFL-2, saccharose, and lactose monohydrate.

Conclusions. The influence of 4 qualitative factors on the compression mixture technological properties, the compressing process and appearance of the tablets based on the Malva sylvestris L. and Plantago lanceolata L. dry extracts have been studied with using the mathematical planning of the experiment (4x4 Greek-Latin square). The excipients which showed the best results of the studied parameters were selected for the further study at the development of the optimal composition and technology of tablets based on Malva sylvestris L. and Plantago lanceolata L. dry extracts.

Author Biographies

S. Ya. Beley, LLC «Ternofarm»

Master «Technology of Pharmaceuticals», Chief Technologist of «Ternofarm» Ltd.

T. A. Hroshovyi, I. Horbachevsky Ternopil State Medical University

Head of the Department of Pharmacy Management and Economics of with Drug Technology, prof. doctor of Pharmaceutical Sciences, I. Horbachevsky Ternopil State Medical University

N. M. Beley, I. Horbachevsky Ternopil State Medical University

Candidate of Pharmaceutical Sciences, PhD (PharmSc), Associate Professor of Department of Pharmacy Management and Economics of with Drug Technology, I. Horbachevsky Ternopil State Medical University

References

State Pharmacopoeia of Ukraine: in 3 vol. / State Enterprise «Ukrainian Research Center expert pharmacopoeia quality medicines.» – 2nd ed. – Kharkiv State Enterprise «Ukrainian Research Center expert pharmacopoeia drug quality,» 2015;1:1128. Ukrainian.

Nosal I. From plant – to man. Stories about medical and medicinal plants of Ukraine. [Від рослини – до людини. Розповіді про лікувальні та лікарські рослини України] – Kyiv: Publishing House Veselka; 1995. Ukrainian.

Samuelsen A B. [The traditional uses, chemical constituents and biological activities of Plantago major L. A review] J. Ethnopharmacol. 2000;1-2:1-21. Ukrainian.

Türel IH, Özbek R, Erten [Hepatoprotective and anti-inflammatory activities of Plantago major L ] Indian J. Pharmacol. 2009; 3:120-124.

Bely SYa, Hroshovy TA. [Determination of optimum conditions for extraction and preparation of dry extract of Plantago lanceolata L.] Pharmaceutical Journal. 2015; 2:22-25. Ukrainian.

Plantago lanceolata L. [Electronic resource, Ukrainian]. Available from: http://www.uicnmed.org/nabp/ database/HTM/PDF/p98.pdf.

Amini M, Kherad M, Mehrabani D. [Effect of Plantago major on Burn Wound Healing in Rat] Journal of Applied Animal Research. 2010;1:37.

Tiwari S. [Plants: A Rich Source of Herbal Medicine] Journal of Natural Products. 2008;1:27-35.

Dipak P. [A review on biological activities of Common Mallow (Malva Sylvestris L.)] Innovare Journal of Life Sciences. 2016;5:1-5.

Beley S Ya.[Definition of the Optimal Conditions for Wild Mallow (Malva Sylvestris) Extraction] The Pharma Innovation Journal. 2017;6:390-392.

Hroshovyi TA, Martseniuk VP, Kucherenko LI, Vronska LV, Hurieieva CM. Mathematical planning of experiment in pharmacy. [Математичне планування експерименту в фармації] Ternopil: Ternopil State Medical University;2008. Ukrainian.

Published

2017-12-29

How to Cite

Beley, S. Y., Hroshovyi, T. A., & Beley, N. M. (2017). INVESTIGATION OF THE PHARMACEUTICAL FACTORS INFLUENCE ON TECHNOLOGICAL PROPERTIES OF THE COMPRESSION MIXTURE АND SOME QUALITY INDICATORS OF TABLETS BASED ON MALVA SYLVESTRIS L. AND PLANTAGO LANCEOLATA L. DRY EXTRACTS. Pharmaceutical Review Farmacevtičnij časopis, (4), 41–49. https://doi.org/10.11603/2312-0967.2017.4.8377

Issue

Section

Pharmaceutical technology, biopharmacy, homeopathy, biotechnology